KRISHNAMOHAN NEHA (Chief Financial Officer) reported 1 transaction at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/5/2024ACC: 0001415889-24-010431
Officer· Chief Financial Officer
Since Jun 2021
-734.09K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
734.09K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−64.09K
Price / share
—
Trade value
—
% of position
New position
4/3/2024
64.09K→0.00
Total
Net shares
−64.09K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/3/2024 | D · Disposition | −64.09K | — | — | New position | 64.09K | 0.00 |
| Total | −64.09K | $0.00 | ||||||
Derivative Transactions3
Stock Option (right to buy)
Direct
Converts to
Common Stock
270K shares
Shares
−270K
Strike price
23.26
Held after
0.00
Exercisable
—
4/3/2024
Stock Option (right to buy)
Direct
Converts to
Common Stock
185K shares
Shares
−185K
Strike price
10.03
Held after
0.00
Exercisable
—
4/3/2024
Stock Option (right to buy)
Direct
Converts to
Common Stock
215K shares
Shares
−215K
Strike price
6.78
Held after
0.00
Exercisable
—
4/3/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock270K shares | 4/3/2024 | D · Disposition | −270K | 23.26 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock185K shares | 4/3/2024 | D · Disposition | −185K | 10.03 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock215K shares | 4/3/2024 | D · Disposition | −215K | 6.78 | — | 0.00 |